Filter
2866
Filtered Results: 2866
Text search:
tuberculosis
burden
Featured
Recommendations
259
New Publications
802
Language
Document type
No document type
1795
Studies & Reports
489
Guidelines
278
Strategic & Response Plan
99
Manuals
90
Situation Updates
43
Fact sheets
38
Training Material
20
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Countries / Regions
India
123
Global
121
Kenya
95
Western and Central Europe
88
South Africa
88
Ethiopia
68
Uganda
63
Nigeria
57
Malawi
54
Tanzania
52
Zambia
51
Africa
49
Liberia
47
Nepal
46
Eastern Europe
45
Rwanda
41
Bangladesh
40
Namibia
40
Myanmar / Burma
40
Ghana
39
Latin America and the Carribbean
37
Sierra Leone
36
Ukraine
33
Asia
31
Lesotho
29
Cambodia
27
South–East Asia Region
27
Indonesia
21
Zimbabwe
19
Mozambique
17
Philippines
16
Russia
16
Botswana
15
Germany
14
East and Southern Africa
14
Congo, Democratic Republic of
12
South Sudan
12
Senegal
11
Syria
10
Haiti
10
Pakistan
10
Colombia
9
Eswatini/ Swaziland
9
West and Central Africa
8
Burkina Faso
7
Venezuela
7
Eastern Europe and Central Asia
7
Tajikistan
6
Albania
6
Afghanistan
6
Peru
6
Middle East and North Africa
6
Brazil
6
Moldova
6
Sudan
6
Somalia
6
Cameroon
5
Guinea
5
Yemen
5
Timor Leste/ East Timor
4
Thailand
4
Benin
4
Jordan
4
Paraguay
4
North America
4
Argentina
4
Papua New Guinea
4
Georgia
4
Iran
3
Laos
3
Armenia
3
Western Pacific Region
3
Lebanon
3
Vietnam
3
Sri Lanka
3
Ecuador
3
North Macedonia
2
China
2
Chile
2
USA
2
Saudi Arabia
2
Turkmenistan
2
Jamaica
2
Southern Africa
2
Romania
2
Palestine
2
Bhutan
2
Iraq
2
Madagascar
2
North Korea
1
Mexico
1
El Salvador
1
Gambia
1
Estonia
1
Burundi
1
Morocco
1
Mongolia
1
Qatar
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Bolivia
1
Djibouti
1
Egypt
1
Greece
1
Central African Republic
1
Poland
1
Honduras
1
Mali
1
Angola
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
1166
Clinical Guidelines
232
Public Health
175
Women & Child Health
79
Key Resources
67
Pharmacy & Technologies
24
Capacity Building
19
Annual Report MEDBOX
1
Toolboxes
TB
568
HIV
423
COVID-19
129
AMR
119
Mental Health
73
NCDs
68
Global Health Education
59
Health Financing Toolbox
56
Planetary Health
50
NTDs
50
Caregiver
49
Rapid Response
39
Refugee
39
Conflict
34
Pharmacy
33
Disability
25
Polio
21
Ebola
19
Natural Hazards
11
Cholera
4
Specific Hazards
2
Social Ethics
2
Zika
2
South Sudan
1
Health Financing
1
The importance of robust mortality surveillance systems cannot be overstated in an era marked by increasing global health challenges where health threats loom large and population dynamics continue to evolve. Accurate and timely mortality data is essential for identifying trends and detecting emergi...
L'importance de systèmes de surveillance de la mortalité robustes ne peut être surestimée à une époque marquée par des défis sanitaires mondiaux croissants, où les menaces sanitaires pèsent lourd et la dynamique des populations continue d'évoluer. Des données précises et opportunes sur ...
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
Background: In 2015, 5.3 million babies died in the third trimester of pregnancy and first month following birth. Progress in reducing neonatal mortality and stillbirth rates has lagged behind the substantial progress in reducing postneonatal and maternal mortality rates. The benefits to prenatal an...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Background:Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how a...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Strengthening resource tracking and monitorig health expanditure
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
Development assistance for health (DAH) has grown substantially, totaling more than $31.3 billion in 2013. However, the degree that countries with high concentrations of armed conflict, ethnic violence, inequality, debt, and corruption have received this health aid and how that assistance might be d...
